Answers are grounded in this paper and cite their sources.
Observational study explores MAGEB2 expression in oral cancer, indicating its potential as a biomarker.
MAGEB2 is a potential biomarker in cancer whereby its protein expression is seen highest in oral cancer.
No takes yet. Share an insight, caveat, or question.
Hasyim et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: